BASF announced the opening of a new global dermatology laboratory in Tarrytown NY. The lab will focus on topical formulations for the pharmaceutical market. Work will include basic research on skin irritation and allergy reactions to full formulations using BASF solubilizers and its broadened excipient portfolio. The laboratory will also support customers in developing new marketing concepts and solving formulation challenges.

BASF will tap into its core expertise in liquid and semi-solid formulations for skin applications. With the integration of the Cognis pharmaceutical-grade excipients in 2010, BASF has increased its range of lipid-based emollients, surfactants, emulsifiers, gelling agents, waxes and solubilizers. The new pharmaceutical excipient portfolio now allows BASF to become a partner in human and animal dermatology, and topical, transdermal and liquid medicines.

The lab will employ a newly formed dermatology team comprising of R&D Scientists, Technical Sales, Marketing and Product Management.